NCT00003207View on ClinicalTrials.gov

Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
SarcomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

pegylated liposomal doxorubicin hydrochloride

DRUG

PSC 833

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Washington University School of Medicine

OTHER

NCT00003207 - Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | Biotech Hunter | Biotech Hunter